Cost effectiveness analysis of a next generation risk assessment score for cardiovascular disease

References

• Go AS, Mozaffarian D, Roger VL, et al. Heart disease and stroke statistics – a 2013 update: a report from the American Heart Association. Circulation 2013;127:e6-245
   PubMed Web of Science ®Google Scholar
• Druss BG, Marcus SC, Olfson M, et al. Comparing the national economic burden of five chronic conditions. Health Aff (Millwood) 2001;20:233-41
   PubMed Web of Science ®Google Scholar
• Heidenreich PA, Trogdon JG, Khavjou OA, et al. Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association. Circulation 2011;123:933-44
   PubMed Web of Science ®Google Scholar
• Yusuf S, Hawken S, Ounpuu S, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004;364:937-52
   PubMed Web of Science ®Google Scholar
• World Health Organization. Data and statistics. http://www.euro.who.int/en/health-topics/noncommunicable-diseases/cardiovascular-diseases/data-and-statistics. Accessed on November 15, 2013
   Google Scholar
• Center for Disease Control and Prevention. Preventable deaths from heart disease & stroke. http://www.cdc.gov/VitalSigns/pdf/2013-09-vitalsigns.pdf. Accessed on November 15th, 2013
   Google Scholar
• Capewell S, Ford ES, Croft JB, et al. Cardiovascular risk factor trends and potential for reducing coronary heart disease mortality in the United States of America. Bull WHO 2010;88:120-30
   PubMed Web of Science ®Google Scholar
• Appel LJ. Empirical support for cardiovascular health: the case gets even stronger. Circulation 2012;125:973-4
   Google Scholar
• Chatellier G, Blinowska A, Menard J, et al. Do physicians estimate reliably the cardiovascular risk of hypertensive patients? Medinfo 1995;8:876-9
   PubMedGoogle Scholar
• Grover SA, Lowensteyn I, Esrey KL, et al. Do doctors accurately assess coronary risk in their patients? Preliminary results of the Coronary Health Assessment Study. BMJ 1995;310:975-8
   PubMed Web of Science ®Google Scholar
• Friedmann PD, Brett AS, Mayo-Smith MF. Differences in generalists’ and cardiologists’ perceptions of cardiovascular risk and the outcomes of preventive therapy in cardiovascular disease. Ann Intern Med 1996;124:414-21
   PubMed Web of Science ®Google Scholar
• Meland E, Laerum E, Stensvold I. Assessment of coronary heart disease risk, I: a postal inquiry among primary care physicians. Fam Pract 1994;11:117-21
   PubMed Web of Science ®Google Scholar
• Montgomery AA, Fahey T, MacKintosh C, et al. Estimation of cardiovascular risk in hypertensive patients in primary care. Br J Gen Practice 2000;50:127-8
   PubMed Web of Science ®Google Scholar
• Khot UN, Khot MB, Bajzer CT, et al. Prevalence of conventional risk factors in patients with coronary heart disease. JAMA 2003;290:898-904
   PubMed Web of Science ®Google Scholar
• Wilson PW, D’Agostino RB, Levy D, et al. Prediction of coronary heart disease using risk factor categories. Circulation 1998;97:1837-47
   PubMed Web of Science ®Google Scholar
• Hill S, Spink J, Cadilhac D, et al. Absolute risk representation in cardiovascular disease prevention: comprehension and preferences of health care consumers and general practitioners involved in a focus group study. BMC Public Health 2010;10:108
   PubMed Web of Science ®Google Scholar
• Virmani R, Burke AP, Farb A, et al. Pathology of the vulnerable plaque. J Am Coll Cardiol 2006;47:C13--C18
   PubMed Web of Science ®Google Scholar
• Naghavi M, Libby P, Falk E, et al. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: part I. Circulation 2003;108:1664-72
   PubMed Web of Science ®Google Scholar
• Cross DS, McCarty CA, Hytopoulos E, et al. Coronary risk assessment among intermediate risk patients using a clinical and biomarker based algorithm developed and validated in two population cohorts. Curr Med Res Opin 2012;28:1819-30
   PubMed Web of Science ®Google Scholar
• Nolan N, Tee L, Vijayakumar S, et al. Analytical performance validation of a coronary heart disease risk assessment multi-analyte proteomic test. Expert Opin Med Diagn 2013;7:127-36
   PubMedGoogle Scholar
• Grundy SM, Cleeman JI, Merz CN, et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation 2004;110:227-39
   PubMed Web of Science ®Google Scholar
• Pearson TA, Blair SN, Daniels SR, et al. AHA Guidelines for primary prevention of cardiovascular disease and stroke: 2002 update: Consensus Panel Guide to comprehensive risk reduction for adult patients without coronary or other atherosclerotic vascular diseases. Circulation 2002;106:388-91
   PubMed Web of Science ®Google Scholar
• National Health, Lung, and Blood Institute. Third Report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adults Treatment Panel III). http://www.nhlbi.nih.gov/guidelines/cholesterol/. Accessed October 16, 2013
   Google Scholar
• National Health, Lung, and Blood Institute. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7). http://www.nhlbi.nih.gov/guidelines/hypertension/. Accessed October 16, 2013
   Google Scholar
• van Kempen BJ, Spronk S, Koller MT, et al. Comparative effectiveness and cost-effectiveness of computed tomography screening for coronary artery calcium in asymptomatic individuals. J Am Col Cardiol 2011;58:1690-701
   PubMed Web of Science ®Google Scholar
• Bild DE, Bluemke DA, Burke GL. Multi-Ethnic Study of Atherosclerosis: objectives and design. Am J Epidemiol 2002;156:871-81
   PubMed Web of Science ®Google Scholar
• Luepker RV, Apple FS, Christenson RH, et al. Case definitions for acute coronary heart disease in epidemiology and clinical research studies: a statement from the AHA Council on Epidemiology and Prevention; AHA Statistics Committee; World Heart Federation Council on Epidemiology and Prevention; the European Society of Cardiology Working Group on Epidemiology and Prevention; Centers for Disease Control and Prevention; and the National Heart, Lung, and Blood Institute. Circulation 2003;108:2543-9
   PubMed Web of Science ®Google Scholar
• Venables WN, Ripley BD. Modern applied statistics with S. 4th ed. New York, NY: Springer, 2002
   Google Scholar
• World Health Statistics. Life tables for WHO Member States. WHO, 2012. http://www.who.int/whois/database/life_tables.cfm. Accessed February 1, 2013
   Google Scholar
• Greenland P, Alpert JS, Beller GA, et al. 2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: executive summary. JACC 2010;56:2182-99
   Google Scholar
• Lim LS, Haq N, Mahmood S, et al. Atherosclerotic cardiovascular disease screening in adults: American College of Preventive Medicine Position Statement on Preventive Practice. Am J Prev Med 2011;40:381.e1-10
   Web of Science ®Google Scholar
• Farley TA, Dalal MA, Mostashari F, et al. Deaths preventable in the U.S. by improvements in use of clinical preventive services. Am J Prev Med 2010;38:600-9
   PubMed Web of Science ®Google Scholar
• Goldman DP, Joyce GF, Karaca-Mandic P. Varying pharmacy benefits with clinical status: the case of cholesterol-lowering therapy. Am J Manag Care 2006;12:21-8
   PubMed Web of Science ®Google Scholar
• Lardizabal JA, Deedwania PC. Benefits of statin therapy and compliance in high risk cardiovascular patients. Vasc Health Risk Manag 2010;6:843-53
   PubMedGoogle Scholar
• Adabag AS, Therneau TM, Gersh BJ, et al. Sudden death after myocardial infarction. JAMA 2008;300:2022-9
   PubMed Web of Science ®Google Scholar
• Nyman JA, Barleen NA, Dowd BE, et al. Quality-of-life weights for the US population: self-reported health status and priority health conditions, by demographic characteristics. Med Care 2007;45:618-28
   Google Scholar
• Pletcher MJ, Earnshaw SR, Auer R, et al. Abstract 11670: using the coronary calcium score to guide statin therapy: a cost-effectiveness analysis. Circulation 2012;126:A11670
   Google Scholar
• Consumer Reports Health. Evaluating statin drugs to treat: high cholesterol and heart disease: comparing effectiveness, safety and price. Consumer Reports. http://www.consumerreports.org/health/resources/pdf/best-buy-drugs/StatinsUpdate-FINAL.pdf. Accessed February 1, 2013
   Google Scholar
• Hong SH, Wang J, Tang J. Dynamic view on affordability of fixed-dose combination antihypertensive drug therapy. Am J Hypertension 2013;26:879-87
   PubMed Web of Science ®Google Scholar